btg's esophageal cancer gel fails in trial
british pharmaceutical group btg said its oncogel treatment did not show any impact on tumors in patients with esophageal cancer and it would not seek a partner for the product.
http://feeds.reuters.com/~r/reuters/healthnews/~3/vh302btcubm/us-btg-idustre73411j20110405
28576
05 Apr 2011 08:50:24
reuters
health